Update shared on24 Sep 2025
Fair value Increased 3.76%Despite a reduced revenue growth outlook, improved net profit margins have driven the consensus analyst price target for DuPont de Nemours up from $89.31 to $92.67.
What's in the News
- DuPont is actively pursuing strategic bolt-on acquisitions, focusing on enhancing capabilities and targeting growth opportunities, while maintaining a balanced approach between buybacks and M&A.
- The company recast its Q3 and full-year 2025 sales guidance to approximately $2.98 billion and $6.87 billion, respectively, following exclusion of Aramids and Qnity businesses as discontinued operations.
- DuPont, Chemours, and Corteva reached a proposed $875 million settlement with the State of New Jersey to resolve legacy environmental and PFAS contamination claims, with DuPont responsible for 35.5% of settlement payments and 71% of a newly established Reserve Fund.
- DuPont launched the FilmTec Hypershell XP RO-8038, an innovative reverse osmosis element designed for the dairy processing industry that offers up to 50% higher productivity or reduced energy demand, improving efficiency and reducing operating costs.
- DuPont and Aero Tec Laboratories expanded their motorsport partnership, introducing crash-resistant fuel bladders made with Kevlar EXO for World Rally Championship cars, with ongoing innovation for other racing series.
Valuation Changes
Summary of Valuation Changes for DuPont de Nemours
- The Consensus Analyst Price Target has risen slightly from $89.31 to $92.67.
- The Consensus Revenue Growth forecasts for DuPont de Nemours has significantly fallen from 3.7% per annum to 3.0% per annum.
- The Net Profit Margin for DuPont de Nemours has risen from 11.76% to 12.68%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.